Human Resource Managemenet
RD Center

Gensenta R&D activities are carried out in accordance with the rules of International Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) determined by the World Health Organization within the framework of national and international regulations and guidelines; many studies such as pre-formulation and formulation development studies, analytical development and validation studies, process improvement studies, bio batch / pilot productions, stability tracking, planning / follow-up of clinical studies are produced.

Gensenta R & D Center always aims to offer human health services to human health by developing effective, safe, patient compliance, innovative economic products that will enable patients to lead a healthier and higher quality life with the research and development of human medicines.

Gensenta, has implemented many R&D projects since its establishment in order to provide quality, reliable and cost-effective products for our country and world people to lead a healthier and happier life. Some of these projects are carried out within the scope of TÜBİTAK-TEYDEB Industry Research and Development Projects Support Program.

The aim of The Scientific and Technological Research Council of Turkey (TUBITAK) - Technology and Innovation Support Programs (TEYDEB) is to develop industrial research, develop and encourage technology development and innovation, and realize university-industry relations. In line with these purposes, TEYDEB supports the research and technology development activities of all institutions located in our country and contributes to the process of transforming technology, which is the most important source of economic development, into social benefit.

TÜBİTAK Industry Research and Development Projects Support Program is carried out to encourage Research and Development studies of organizations that create added value at the firm level and in this way to contribute to the enhancement of the R&D capability of the Turkish industry.

Our project titled “Development of Injectable Oncolytic Product Formulations”, one of our projects supported within the scope of “1501 Industry R&D Projects Support Program” provided by TÜBİTAK - TEYDEB, was shown among the successful project examples among the projects supported by Tübitak-Teydeb in 2011 and was included in the relevant catalog study.